OTCMKTS:XCRT Xcelerate (XCRT) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free XCRT Stock Alerts $0.04 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.03▼$0.0450-Day Range$0.03▼$0.0552-Week Range$0.03▼$0.14Volume2,200 shsAverage Volume126,338 shsMarket Capitalization$15.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get Xcelerate alerts: Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About Xcelerate Stock (OTCMKTS:XCRT)Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.Read More XCRT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XCRT Stock News HeadlinesJanuary 19, 2024 | finance.yahoo.comXcelerate, Inc. Announces Participation in The Microcap ConferenceOctober 24, 2023 | finance.yahoo.comXcelerate, Inc. Announces Publication of its Two Utility Patent ApplicationsApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.September 14, 2023 | stockhouse.comXcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange ServiceSeptember 14, 2023 | finance.yahoo.comXcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange ServiceAugust 8, 2023 | finanznachrichten.deXcelerate, Inc.: Xcelerate Announces Marketing AgreementAugust 8, 2023 | finance.yahoo.comXcelerate Announces Marketing AgreementJuly 25, 2023 | finance.yahoo.comXcelerate, Inc. Acquires a Majority Interest in ESN GroupApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.April 20, 2023 | finance.yahoo.comXcelerate, Inc. Announces PTO and PCT Filings For Surgical DevicesApril 12, 2023 | finance.yahoo.comXcelerate, Inc. Announces Agreement to Acquire a Controlling Interest in ESN, Inc.March 14, 2023 | finanznachrichten.deXcelerate, Inc.: Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of TanzaniaMarch 14, 2023 | finance.yahoo.comXcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of TanzaniaFebruary 1, 2023 | finance.yahoo.comFabian Urquijo Joins the Advisory Board of Xcelerate, Inc.January 17, 2023 | finanznachrichten.deXcelerate, Inc.: Xcelerate Inc. to Acquire Controlling Interest in ESN Group, IncJanuary 17, 2023 | seekingalpha.comXcelerate to acquire controlling interest in ESN GroupJanuary 17, 2023 | finance.yahoo.comXcelerate Inc. to Acquire Controlling Interest in ESN Group, IncJanuary 3, 2023 | finance.yahoo.comXcelerate, Inc. Releases Message from CEOAugust 31, 2022 | proactiveinvestors.comXcelerate Inc: Spanning divide between engineering advancements and application to clinical careAugust 30, 2022 | finance.yahoo.comXcelerate, Inc. to Develop Consumer Healthcare ProductsAugust 24, 2022 | finanznachrichten.deXcelerate, Inc.: Additional Countries Add Patent ProtectionAugust 23, 2022 | finance.yahoo.comAdditional Countries Add Patent ProtectionAugust 16, 2022 | finance.yahoo.comXcelerate Inc. (XCRT)August 3, 2022 | yahoo.comLove Island’s Luca Bish slammed again for ‘over-reacting’August 2, 2022 | yahoo.comDelaware masking guidance changes as all three counties have 'high' spread of COVIDAugust 2, 2022 | yahoo.comLoyal man charged with hit-and-runAugust 1, 2022 | finance.yahoo.comXcelerate, Inc. Announces Uplisting to OTCQB MarketSee More Headlines Receive XCRT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xcelerate and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health services Sub-IndustryN/A Current SymbolOTCMKTS:XCRT CUSIPN/A CIK1138586 Webnewudhi.com Phone(854) 900-2020FaxN/AEmployees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares434,450,000Free FloatN/AMarket Cap$15.38 million OptionableNot Optionable Beta2.73 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. George D. Green (Age 64)CFO & Secretary Comp: $114kMr. Michael F. O'Shea (Age 73)President, CEO & Chairman Dr. Anja Glisovic-Rosch (Age 46)Interim Chief Science Officer Key CompetitorsUpHealthNYSE:UPHLAgape ATPNASDAQ:ATPCCovalon TechnologiesOTCMKTS:CVALFUnion DentalOTCMKTS:UDHIPear TherapeuticsNASDAQ:PEARView All Competitors XCRT Stock Analysis - Frequently Asked Questions How have XCRT shares performed in 2024? Xcelerate's stock was trading at $0.0360 at the start of the year. Since then, XCRT stock has decreased by 1.7% and is now trading at $0.0354. View the best growth stocks for 2024 here. How do I buy shares of Xcelerate? Shares of XCRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:XCRT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWall Street Legend Issues New NVDA WarningChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican Alternativetop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xcelerate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
